These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3264427)

  • 1. Priming of cytotoxic T lymphocyte precursors by donor-specific transfusions and modulation post transplant in relation to steroid withdrawal.
    Burlingham WJ; Grailer A; Sollinger HW
    Transplant Proc; 1988 Dec; 20(6):1166-8. PubMed ID: 3264427
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of donor-specific cytotoxic T lymphocyte precursors after transfusion.
    Vandekerckhove BA; van Bree S; Zhang L; Datema G; Zantvoort F; Claas FH
    Transplantation; 1989 Oct; 48(4):672-5. PubMed ID: 2799922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific cytotoxic T-cell alloreactivity in successfully engrafted high-risk cornea patients.
    Ruiz P; Foulks GN; Sanfilippo F
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3153-5. PubMed ID: 2650443
    [No Abstract]   [Full Text] [Related]  

  • 4. Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
    Masucci MG; Torsteinsdottir S; Pear W; Carstensen A; Klein E
    J Immunol; 1984 Oct; 133(4):1755-62. PubMed ID: 6236256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation.
    Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA
    Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC).
    Sondel PM; Hank JA; Rosenthal N; Moore KH; Hong R; Storer B; Kohler PC
    Prog Clin Biol Res; 1987; 244():173-84. PubMed ID: 3498947
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of cytolytic T cell function by lectins.
    Toribio ML; de la Hera A; Pereira P; de Landázuri MO
    J Immunol; 1985 Apr; 134(4):2179-84. PubMed ID: 3871807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC 45662).
    Weir MR; Li XW; Gomolka D; Peppler R; O'Bryan-Tear G; Moran M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1074-7. PubMed ID: 1989152
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 10. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immune responses after donor-specific transfusion (DSBT).
    Kovithavongs T; Sharma R; Schlaut J; Burzminski D; Pazderka F; Harley F; Dossetor JB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1822-4. PubMed ID: 2652592
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
    Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
    J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency analysis of donor-reactive cytotoxic T lymphocyte precursors in in allograft recipients. Lack of correlation with clinical outcome.
    Eberspächer ML; Otto G; Herfarth C; Kabelitz D
    Transplantation; 1994 Jun; 57(12):1746-52. PubMed ID: 8016880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic lymphocyte responses by antigen-specific helper factors.
    Krowka JF; Shiozawa C; Diener E; Paetkau V; Pilarski LM
    J Immunol; 1984 Oct; 133(4):2018-24. PubMed ID: 6206146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific cytotoxic T-cell unresponsiveness in long-term stable renal allograft recipients.
    Fujiwara T; Sakagami K; Saitoh S; Uda M; Orita K
    Transplant Proc; 1994 Aug; 26(4):2161-4. PubMed ID: 8066709
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K; Tilden AB; Balch CM
    Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of cytotoxic T cell function in cardiac transplant recipients: the immediate posttransplant period.
    Cohen DJ; Mohanakumar T; Johns C; Goldman MH; Wolfgang T; Szentpetery S; Lee HM; Lower RR
    Transplant Proc; 1984 Dec; 16(6):1512-3. PubMed ID: 6239422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.